Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
about
Sulodexide and glycosaminoglycans in the progression of renal diseaseComparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytesAutocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levelsAnti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathyEffect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial.Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide.Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.Modulation of endothelial glycocalyx structure under inflammatory conditions.Role of the vascular wall in sodium homeostasis and salt sensitivity.Diabetic nephropathy: landmark clinical trials and tribulations.Therapies on the Horizon for Diabetic Kidney Disease.Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations.Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion.Effect of sulphated polysaccharides on erythrocyte changes due to oxidative and nitrosative stress in experimental hyperoxaluria.Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration.Activities of Lysosomal Enzymes in Alloxan-Induced Diabetes in the Mouse.
P2860
Q26991825-7D619E75-88D1-422B-9166-6F8275A79E86Q33385947-27F0BB50-2487-403D-A375-536904A19C48Q33676356-CDCDAB8F-9614-4D83-BB98-789AEA41FF8CQ33793187-CCAE4F72-53F1-4333-822C-0AEEB6B55322Q33834001-914D5967-C492-411A-BCD0-4C64169BB25AQ35014833-866E3749-1AB5-4C55-B6F1-38BAB1BD7906Q35239936-B946DFAA-DE27-406C-8BBB-D84FAB971F07Q35412466-92CA1968-B602-45CA-99F5-FD81B9082DF6Q35720773-72223C3C-6D13-4691-9D8A-AD26F938A961Q36323528-1D5033C6-0904-4859-8799-9B135E3CCF8CQ37691659-3F17C21D-CF8B-4CEC-8411-84FB7E7013C5Q38209920-897C420A-BAB1-42BC-8D23-921616CDE2F8Q38258022-1B06E587-4490-4382-B962-0D9E1B453903Q38338539-96F8E6C1-71BD-4544-B910-0A71AA30FCBEQ38605099-233FB000-1681-4270-9E5C-FEEDC278B154Q42486771-6E81C4FB-0224-4C83-A52A-5FAB0841509AQ44695940-51E2AD4A-35E1-4D57-9B68-D51E26079C5EQ46674728-20A6C85A-933F-48D4-A54A-7E3BB8D537E8Q47352965-6B334F10-C51E-4C7A-9494-04223EF9BA1AQ50109954-35016FDE-F9EB-4C55-AF85-DD4A508AEFB4
P2860
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@ast
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@en
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@nl
type
label
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@ast
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@en
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@nl
prefLabel
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@ast
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@en
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@nl
P2093
P356
P1433
P1476
Treatment with a glycosaminogl ...... rimental diabetic nephropathy.
@en
P2093
A Borsatti
A P Venturini
A Pesarini
C Milanesi
D M Noonan
P2888
P304
P356
10.1038/KI.1994.335
P407
P577
1994-09-01T00:00:00Z
P6179
1034851355